Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Non Operating Income (2016 - 2025)

Amicus Therapeutics filings provide 14 years of Non Operating Income readings, the most recent being -$2.2 million for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 188.14% to -$2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.2 million, a 208.51% increase, with the full-year FY2025 number at $10.2 million, up 208.51% from a year prior.
  • Non Operating Income hit -$2.2 million in Q4 2025 for Amicus Therapeutics, down from $10.9 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $13.6 million in Q3 2022 to a low of -$18.6 million in Q4 2022.
  • Median Non Operating Income over the past 5 years was $31000.0 (2021), compared with a mean of -$690400.0.
  • The widest YoY moves for Non Operating Income: up 5652.74% in 2022, down 10730.23% in 2022.
  • Amicus Therapeutics' Non Operating Income stood at -$172000.0 in 2021, then tumbled by 10730.23% to -$18.6 million in 2022, then skyrocketed by 84.54% to -$2.9 million in 2023, then skyrocketed by 187.01% to $2.5 million in 2024, then tumbled by 188.14% to -$2.2 million in 2025.
  • The last three reported values for Non Operating Income were -$2.2 million (Q4 2025), $10.9 million (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.